Sentetik kannabinoidlerden JWH-018'in kardiyovasküler etkileri

The aim of this review is to highlight cardiovascular effects of JW-018 which is considered to be the prototype for synthetic cannabinoids to prepare the ground for new work to be done

📌 3 Key Takeaways

🎯

Objective & Hypothesis:The content of synthetic cannabinoids (SC) which are known in Europe as 'Spice', in the U.S.A. as K2', and in Turkey as 'Bonsai' or 'Jamaica' is not standardized.

📊

Key Findings & Data:Also SC are known to contain approximately 400 chemical compounds which vary from country to country.

💡

Conclusion & Impact:The aim of this review is to highlight cardiovascular effects of JW-018 which is considered to be the prototype for synthetic cannabinoids to prepare the ground for new work to be done

🔬Design:Review & Systematic Survey

📍Scope:2014 Verileri

⚙️Variables:Domain Parameters

Abstract

The content of synthetic cannabinoids (SC) which are known in Europe as 'Spice', in the U.S.A. as K2', and in Turkey as 'Bonsai' or 'Jamaica' is not standardized. Also SC are known to contain approximately 400 chemical compounds which vary from country to country. SC mimics the effect of ?9tetrahydrocannabinol (THC) which is the major effective content of Cannabis or Marijuana by cannabinoid-1 (CB1) and cannabinoid-2 (CB2) receptors in the body cell. Although the new SCs are synthesized and the number of new derivatives is increased in every day; JWH-018 among these derivatives exerts full agonist effect on both CB1 and CB2 receptors also it has a short-term effect as 2 hours. For this reason, JWH-018 is the most commonly used as SC. There are a few data in the literature regarding to the pharmacokinetic and pharmacodynamic effects of SC. Furthermore, most of the existing data are based on in vitro experiments. In the JWH-018 report, at Critical Review Report Agenda item 4.5 Expert Committee on Drug Dependence of World Health Organization (WHO), Thirty-sixth Meeting Geneva, 16-20 June 2014, is declared that despite a marked elevation of the heart rate is one of the clinical signs very often seen after intoxication with SC, there is no available study data regarding effects of SCs on cardiovascular, respiratory, gastrointestinal, genitourinary systems, liver and kidney tissues . The aim of this review is to highlight cardiovascular effects of JW-018 which is considered to be the prototype for synthetic cannabinoids to prepare the ground for new work to be done

Özet

Avrupa'da 'Spice', ABD'de 'K2', Türkiye'de 'Bonzai' ya da 'Jamaika' olarak adlandırılan sentetik kannabinoid (SK)'lerin içerikleri sabit olmadığı gibi; ülkeden ülkeye değişiklik gösteren yaklaşık 400 kadar kimyasal bileşik içerdiği bilinmektedir. SK'lar vücut hücrelerinde kannabinoid-1 (CB1) ve kannabinoid2 (CB2) reseptörleri ile etkileşerek Hint keneviri ya da esrarın içindeki majör etken madde olan ?9-tetrahidrokannabinol (THC)'ün etkisini taklit ederler. Her ne kadar yeni SK'lar sentezlenip, yeni türevlerin sayıları gün geçtikçe artsa da; bu türevler arasında JWH-018, hem CB1 ve CB2 reseptörlerine tam agonist hem de 2 saat gibi kısa etki süreli olması nedeniyle en sık kullanılan SK'dır. SK'ların farmakokinetik ve farmakodinamik etkileri hakkında literatürde oldukça az veri bulunmaktadır ve mevcut verilerin çoğu da in vitro deneylere dayanmaktadır. Dünya Sağlık Örgütü (WHO)'nün 16-20 Haziran 2014 tarihinde Cenevre'de gerçekleştirdiği Uyuşturucu Bağımlılığı Uzman Komitesinin 36. Toplantısında sunulan JWH-018 raporunda, SK'lara bağlı intoksikasyonda belirgin kalp hızı artışının oldukça sık görüldüğü belirtilmesine rağmen; kardiyovasküler, solunum, gastrointestinal, genitoüriner sistem, karaciğer ve böbrek dokuları üzerine olan etkileri hakkında yeterli veriye ulaşılmadığı belirtilmiştir.Bu derlemedeki amaç, SK'lar için prototip olarak kabul edilen JW-018'in kardiyovasküler sistem üzerindeki etkilerini ortaya koyarak yapılacak yeni çalışmalara zemin hazırlamaktır

🔖

Cite This Article

PARLAKPINAR, H., CELBİŞ, O., OZHAN, O., PETEKKAYA, S., ŞAMDANCI, E., ERMİŞ, N., KOPARİR, P., SOYLU, Ö., ACET, H. A. (2016). Sentetik kannabinoidlerden JWH-018'in kardiyovasküler etkileri. Medicine Science, Cilt: 5 - Sayı: 4, 1049–1054. https://ajindex.com/articles/277582

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (12)

Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of spice products (synthetic cannabinoids). Drug Alcohol Depend. 2012;120(1-3):238-41.
Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the national poison data system in 2010. Ann Emerg Med. 2012;60(4):435-8.
Sun Y, Bennett A. Cannabinoids: a new group of agonists of PPARs. PPAR Res. 2007;2007:23513. Pertwee RG. Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr Med Chem. 2010;17(14):1360-81.
Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett. 2010;197(3):157-62. Geller T. Cannabinoids: a secret history. Chem Heritage Magazine. 2007;25(2):1-5.
Fattore L, Fratta W. Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci. 2011;5(60):1-12.
Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International Union of Pharmacology. XXVII. Classification 2002;54(2):161-202. receptors. Pharmacol Rev. Huffman JW, Padgett LW. Recent developments in the medicinal chemistry of cannabinomimetic indoles, pyrroles and indenes. Curr Med Chem.2005;12(12):1395-411.
Mechoulam R, Feigenbaum JJ, Lander N, Segal M, Jarbe TU, Hiltunen AJ, Consroe P. Enantiomeric cannabinoids: stereospecificity of psychotropic activity. Experientia. 1988;44(9):762-4. World Health Organization (WHO). JWH-018 critical review report agenda item 4.5. Expert Committee on Drug Dependence Thirty-sixth Meeting. 2014;1-3.
Quan D, HaaseD, Levitan R. Legal drugs of abuse. Emerg Med Rep. 2011;32(20):237-47. Türkiye Uyuşturucu ve Uyuşturucu Bağımlılığı İzleme Merkezi (TUBİM). Türkiye uyuşturucu raporu. T.C. İçişleri Bakanlığı Emniyet Genel Müdürlüğü Kaçakçılık ve Organize Suçlarla Mücadele Daire Başkanlığı, 2014.
Ankara, Turkey. Maxwell JC. Psychoactive substances - some new, some old: a scan of the situation in the U.S. Drug Alcohol Depend. 2014;134:71-7.
Mir A, Obafemi A, Young A, Kane C. myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics. 2011;128(6):1622-7.
Johnston LD, O'Malley PM, Bachman JG. The rise in teen marijuana use stalls, synthetic marijuana use levels, and use of 'bath salts' is very low. University of Michigan News Service. 2012;1-6.
Castellanos D, Singh S, Thornton G, Avila M